SENS NASDAQ
Credit Risk of going bust: higher than 70% of companies Debt: 13.5% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.16 (down 98%), Senseonics Holdings, Inc. would be worth roughly what it owes.
Total debt $61.8M against a stock market value of $395.5M.
Distance to default 3.44 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $27.9M (short-term plus half of long-term), stock volatility 77.4%; Altman Z -6.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Germantown, MD 20876-7005
US
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Prince Douglas S | A-Award | 815 | $9.96 | 2026-10-01 |
| ROEDER DOUGLAS A | A-Award | 1,480 | $9.96 | 2026-10-01 |
| Fiorentino Edward | A-Award | 1,418 | $9.96 | 2026-10-01 |
| Steven Edelman | A-Award | 1,292 | $9.96 | 2026-10-01 |
| ROEDER DOUGLAS A | P-Purchase | 13,953 | $8.98 | 2026-08-19 |